Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 United States; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6735-61
Published February 26, 2020 · Recall initiated: December 13, 2019
Summary
FDA records drug Class III recall D-0844-2020, published February 26, 2020 and initiated December 13, 2019. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 246 Cartons; Lot: Lot# M02465D. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: High out of specification result observed at stability studies.
What to do
Voluntary: Firm initiated · Letter
Get an email if MEMANTINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MEMANTINE HYDROCHLORIDE
- Manufacturer
- The Harvard Drug Group
- Distributor
- U.S.A. Nationwide
- Lot
- Lot# M02465D
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMemantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only,April 22, 2026
- FDAMemantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only,May 20, 2020
- FDADesmopressin Acetate Tablets, 0.1 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged andFebruary 26, 2020
- FDAMemantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: LupinFebruary 19, 2020
- FDACoopervision Vertex Toric /2 Clear Toric- Power -2.50 -0.75 /90 Soft (hydrophilic) Contact Lens (extendedFebruary 19, 2020
- FDATerumo AZUR CX Peripheral Coil System, Detachable 35, CX Coil, REF numbers 45-751019, 45-751324, 45-751632,February 19, 2020
Questions about this recall
Was Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 United States; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6735-61 recalled?
Yes. FDA published recall D-0844-2020 on February 26, 2020. Reported hazard: Failed Dissolution Specifications: High out of specification result observed at stability studies.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MEMANTINE HYDROCHLORIDE.